Multiplex qualitative real‑time PCR kit for the syndromic approach to gastrointestinal infections.
Product description
The GastroFinder® 2Smart kit is an advanced qualitative in vitro diagnostic test designed for the rapid diagnosis and syndromic management of gastrointestinal infections. Its high‑throughput multiplex design allows the simultaneous identification of 18 of the most common and clinically relevant gastroenteritis‑causing pathogens (bacteria, parasites, and viruses) in a single reaction.
Its optimised workflow provides results in approximately 2.5 hours after the nucleic acid extraction process. Thanks to high‑resolution melting curve analysis, the platform ensures precise differentiation of microorganisms, facilitating early therapeutic intervention, reduction of nosocomial outbreaks, and effective epidemiological control.
Pathogens detected (18)
The panel simultaneously identifies and differentiates the following 18 pathogenic microorganisms from stool samples:
Bacteria (9)
Campylobacter spp.
Salmonella spp.
Yersinia enterocolitica
Clostridium difficile toxin A
Clostridium difficile toxin B
Shiga toxin‑producing Escherichia coli (STEC) stx1/stx2
Enteropathogenic Escherichia coli (EPEC) eae
Enterotoxigenic Escherichia coli (ETEC) elt/est
Shigella / Enteroinvasive Escherichia coli (EIEC) ipaH
Parasites (4)
Entamoeba histolytica
Giardia lamblia
Cryptosporidium spp.
Dientamoeba fragilis
Viruses (5)
Norovirus (GI/GII/GIV)
Rotavirus (A)
Adenovirus (40/41)
Astrovirus
Sapovirus (GI/GII/GIV/GV)
Key advantages and features
Comprehensive Syndromic Approach: Detects 18 respiratory and gastrointestinal pathogens in a single analysis, accelerating the screening process compared to traditional culture methods.
Maximum Sensitivity: Offers a clinical sensitivity level equivalent to individual singleplex real‑time PCR assays.
Results in Record Time: Amplification and detection process completed in just 2.5 hours after extraction.
Validated Sample and Extraction: Optimised for stool samples. The nucleic acid extraction method has been validated using the automated NuclisENS® easyMAG® platform (bioMérieux).
Complete Quality Control: The kit includes ready‑to‑use Internal Control (IC), Amplification Controls (AC) and Positive Control (PC), ensuring the technical reliability of the assay.
Interpretation Software: Digital support with result interpretation software available to facilitate the reading and reporting workflow.
×